About Enhancer

Enhancer ID: E_02_0938
Species: human
Position : chr11:8301851-8303851
Biosample name:
Experiment class : Low throughput
Enhancer type: Enhancer
Disease: T-cell leukemia
Pubmed ID:  23302769
Enhancer experiment: ChIP,RT-PCR,Luciferase Reporter Assay
Enhancer experiment description: The LMO1 promoters display bivalent histone marks in multiple blood lineages including T-cells, and a 3 flanking region at LMO1 ? 57 contains a transcriptional enhancer that is active in developing blood cells in transgenic mouse embryos. The LMO1 promoters become activated in T-ALL together with the 3 enhancer, which is bound in primary T-ALL cells by SCL/TAL1 and GATA3.

About Target gene

Target gene : LMO1(RBTN1,RHOM1,TTG1)
Strong evidence: --
Less strong evidence: ChIP,RT-PCR,Luciferase Reporter Assay
Target gene experiment description: To investigate whether lack of expres_x0002_sion in the haematopoietic system may be due to active repression of the two LMO1 promoters, we analysed ChIP-Sequencing data released to the public domain by the NIH Roadmap Epigeno_x0002_mics Mapping Project.

About TF

TF name : TAL1(SCL,TCL5,bHLHa17,tal-1)GATA3(HDR,HDRS)
TF experiment: ChIP,qPCR
TF experiment description: ChIP assays on T-ALL cells from the same primagraft (X31) using antibodies against SCL/TAL1and GATA3. Analysis by quantitative PCR demonstrates significant binding of both SCL/TAL1 and GATA3 to the LMO1 +57 enhancer, with no binding to either of the two LMO1 promoters.

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs